Sign in

CIK 0001585608

  • Non-accelerated filer
  • Smaller reporting company

Jaguar Health, Inc.

Sign in to watch
Ticker
JAGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 415-371-8300
Business address
200 PINE STREET SUITE 400, SAN FRANCISCO, CA, 94104
Former names
Jaguar Animal Health, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 83 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-04-06 Jayasuriya Anula Director Grant or award · Restricted stock units −1,718 1,718
2023-04-05 Chaturvedi Pravin R Chief Scientific Officer Option exercise +133 266
2023-04-05 Chaturvedi Pravin R Chief Scientific Officer Grant or award · Restricted stock units +133 134
2023-04-05 Chaturvedi Pravin R Chief Scientific Officer Option exercise +44 88
2023-04-05 Chaturvedi Pravin R Chief Scientific Officer Grant or award · Restricted stock units +44 44
2023-04-05 Lizak Carol R. Chief Financial Officer Option exercise +60 226
2023-04-05 Lizak Carol R. Chief Financial Officer Grant or award · Restricted stock units +60 60
2023-04-05 Wolin Jonathan S. Chief of Staff, CCO & GC Option exercise +88 181
2023-04-05 Wolin Jonathan S. Chief of Staff, CCO & GC Grant or award · Restricted stock units +88 88
2023-04-05 King Steven R. Chief of Sustainable Supply Option exercise +177 354
2023-04-05 King Steven R. Chief of Sustainable Supply Grant or award · Restricted stock units +177 177
2023-04-05 CONTE LISA A CEO and President Option exercise +600 1,306
2023-04-05 CONTE LISA A CEO and President Grant or award · Restricted stock units +600 600
2022-12-31 Wolin Jonathan S. Chief of Staff, CCO & GC Purchase +317 $0.03 $10 6,983
2022-12-27 Chaturvedi Pravin R Chief Scientific Officer Returned to the company · Employee Stock Option (right to buy) −31,667 0
2022-12-27 Wolin Jonathan S. Chief of Staff, CCO & GC Returned to the company · Employee Stock Option (right to buy) −21,112 0
2022-12-27 Lizak Carol R. Chief Financial Officer Returned to the company · Employee Stock Option (right to buy) −14,294 0
2022-12-27 King Steven R. Chief of Sustainable Supply Returned to the company · Employee Stock Option (right to buy) −42,223 0
2022-12-27 CONTE LISA A CEO and President Returned to the company · Employee Stock Option (right to buy) −142,500 0
2022-05-18 Divis Gregory J Director Option exercise +12,133 12,133

Page 7 of 10 · 185 trades